RMC-5127

· Revolution Medicines, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RMC-5127, covering 2026-02-04 to 2026-02-04. Get the full timeline:

Most recent: Clinical Trial Update: Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors [Phase 1]